Form 6-K Biophytis SA For: Mar 17 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biophytis Announces Ratio Change Under its American Depositary Receipt Program PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / March 17, 2023 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS) (the "Company"…
Form 6-K Biophytis SA For: Mar 09 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 9, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or…
Biophytis Announces the Signature of a Master Service Agreement With Intsel Chimos, a Pharmaceutical Company That Will Operate Sarconeos in France for the Treatment of Severe Forms of COVID-19 Biophytis and Intsel Chimos signed a master service agreement under which Intsel Chimos will be the operating pharmaceutical company/exploitant, partner…
Form 6-K Biophytis SA For: Feb 28 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biophytis Initiates the Regulatory Process for an Early Access Authorization in France from the French National Authority for Health for the Treatment with Sarconeos of Severe Forms of COVID-19 Biophytis to present the early access application in France at a pre-filing meeting in March with the HASBiophytis plans to…
Form 6-K Biophytis SA For: Feb 23 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biophytis Announces Positive Final Results of the Phase 2-3 COVA Study with Sarconeos in Severe COVID-19 COVA study met primary end point with 44% significant reduction in the risk of respiratory failure or early deathFiling for…
Form 6-K Biophytis SA For: Jan 31 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K Biophytis SA For: Jan 30 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Scheduled For January 31, 2023 Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter. read more...…
Biophytis GAAP EPS of -€0.08 Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biophytis Publishes its Financial Results for the First Half of 2022 Cash and cash equivalents: €19.7m as of June 30, 2022Net loss down 8% at €12.4m for first half of 2022Publication…
THE PARIS COURT OF APPEAL CONFIRMS THE CONVICTION OF BIOPHYTIS, OPENING THE RIGHT FOR NEGMA GROUP TO CLAIM COMPENSATION FOR ITS ENTIRE LOSS Full and original release on www.actusnews.com. Subscribe to this companys information....…
Form 6-K Biophytis SA For: Jan 19 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K Biophytis SA For: Jan 06 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…